Crossmark

Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm

Published Online: 2024-09-16

Published Print: 2024-10

Authors

Brito-Dellan, Norman

Franco-Vega, Maria Cecilia

Ruiz, Juan Ignacio

Lu, Maggie

Sahar, Hadeel

Rajapakse, Pramuditha

Lin, Heather Y.

Peterson, Christine

Leal-Alviarez, Daniel

Altay, Haider

Tomy, Sophy

Manzano, Joanna-Grace Mayo
Funding

Funding for this research was provided by:

National Institutes of Health/National Cancer Institute (Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672, Award number P30CA 016672)

Division of Internal Medicine Research and Quality Improvement Development Award at the University of Texas MD Anderson Cancer Center
License Information

Text and Data Mining valid from 2024-09-16

Version of Record valid from 2024-09-16
More Information

Article History

Received: 3 April 2024

Accepted: 9 September 2024

First Online: 16 September 2024

Declarations

:

: This quality improvement study was approved by the Quality Improvement Approval Board (QIAB) at MD Anderson Cancer Center. Ethical approval was not required by the reviewing/approving body.

: Not applicable.

: Not applicable. There is no patient-identifiable data in this publication.

: The authors declare no competing interests.

Document is current